Literature DB >> 656275

Chlorpromazine levels in plasma and milk of nursing mothers.

D H Wiles, M W Orr, T Kolakowska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 656275      PMCID： PMC1429278          DOI： 10.1111/j.1365-2125.1978.tb01639.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  3 in total

1.  Cardiac arrest after ECT.

Authors:  S NYSTROEM
Journal:  Am J Psychiatry       Date:  1962-08       Impact factor: 18.112

2.  Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector.

Authors:  S H Curry
Journal:  Anal Chem       Date:  1968-07       Impact factor: 6.986

3.  Clinical significance of plasma chlorpromazine levels. I. Plasma levels of the drug, some of its metabolites and prolactin during acute treatment.

Authors:  D H Wiles; T Kolakowska; A S McNeilly; B M Mandelbrote; M G Gelder
Journal:  Psychol Med       Date:  1976-08       Impact factor: 7.723
  3 in total
  10 in total

Review 1.  Antipsychotics and breast-feeding: a review of the literature.

Authors:  T Tényi; G Csábi; M Trixler
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

Review 2.  The quality of lactation studies including antipsychotics.

Authors:  Hazel Hummels; Daphne Bertholee; Douwe van der Meer; Jan Pieter Smit; Bob Wilffert; Peter Ter Horst
Journal:  Eur J Clin Pharmacol       Date:  2016-08-24       Impact factor: 2.953

3.  Adverse effects of antipsychotic agents.

Authors:  G M Simpson; E H Pi; J J Sramek
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

4.  Milk concentrations of flupenthixol, nortriptyline and zuclopenthixol and between-breast differences in two patients.

Authors:  I Matheson; J Skjaeraasen
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  The potential risks of commonly prescribed antipsychotics: during pregnancy and lactation.

Authors:  Mohammad Masud Iqbal; Alka Aneja; Atiq Rahman; James Megna; Wanda Freemont; Mohammed Shiplo; Nikil Nihilani; Kathy Lee
Journal:  Psychiatry (Edgmont)       Date:  2005-08

Review 6.  A guide to the safety of CNS-active agents during breastfeeding.

Authors:  C A Chisholm; J A Kuller
Journal:  Drug Saf       Date:  1997-08       Impact factor: 5.606

Review 7.  Excretion of psychoactive drugs into breast milk. Pharmacokinetic principles and recommendations.

Authors:  G Pons; E Rey; I Matheson
Journal:  Clin Pharmacokinet       Date:  1994-10       Impact factor: 6.447

8.  Concentrations of Cis(Z)-flupentixol in maternal serum, amniotic fluid, umbilical cord serum, and milk.

Authors:  L Kirk; A Jørgensen
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

9.  Presence of chlorprothixene and its metabolites in breast milk.

Authors:  I Matheson; A Evang; K F Overø; G Syversen
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Zuclopenthixol levels in serum and breast milk.

Authors:  T Aaes-Jørgensen; F Bjørndal; U Bartels
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.